Evidence map›Paper›PMID 25737773›Full record

ArticleInternational journal of organ transplantation medicine2015

Polymorphism of Transcription Factor-7-Like 2 (TCF7L2) Gene and New-Onset Diabetes after Liver Transplantation.

Z Musavi, N Azarpira, M H Sangtarash, M Kordi, K Kazemi, B Geramizadeh, S A Malek-Hosseini

Abstract read
In one paragraph

Article in International journal of organ transplantation medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Z MusaviTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran ; Department of Genetic, Sistan and Baluchestan University of Sciences, Zahedan, Iran.
N AzarpiraTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
M H SangtarashTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran ; Department of Genetic, Sistan and Baluchestan University of Sciences, Zahedan, Iran.
M KordiDepartment of Genetic, Sistan and Baluchestan University of Sciences, Zahedan, Iran.
K KazemiTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
B GeramizadehTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
S A Malek-HosseiniTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNew-onset diabetes after transplantation (NODAT) is a serious complication in transplant recipients. Transcription factor-7-like 2 (TCF7L2) is a Wnt signaling-associated transcription factor that plays an important role in β-cell proliferation and insulin secretion. The association between TCF7L2 SNP rs7903146 and NODAT was documented in renal transplant patients.

objectiveTo determine the association between TCF7L2 rs7903146 variants and the risk of NODAT after liver transplantation.

methodsThis study was conducted on 140 liver transplant recipients who had received tacrolimus-based immunosuppressive drugs. The patients were divided into NODAT (n=70) and non-NODAT (n=70) groups and were genotyped using PCR-RFLP. In addition, 100 normal subjects were considered as the comparison group.

resultsThere was a significant difference (p<0.05) between the two study groups regarding donor and recipient age, recipient body mass index, and recipient fasting plasma glucose before the transplantation. No significant relationship was observed between TCF7L2 rs7903146 genotypes and development of NODAT. No significant difference was also found between the two groups in terms of the tacrolimus and mycophenolate mofetil daily dosage as well as tacrolimus blood level. However, the prednisolone daily dosage was significantly (p=0.01) higher in the NODAT group compared to those without NODAT. The majority of the patients in the NODAT group also had an episode of acute rejection. Furthermore, a significant difference was found between the transplant recipients and the comparison subjects regarding T allele (p<0.001, OR=1.96) and TT genotype (p<0.001, OR=3.47) frequencies.

conclusionNo correlation was found between TCF7L2 genotypes and development of NODAT. Acute rejection and prednisolone pulse therapy predisposed the susceptible patients to NODAT.

Indexed as

Diabetes mellitusgeneticLiver transplantationPolymorphismTranscription factor 7-like 2 proteinTranscription factors

Identifiers

PMID25737773
PMCPMC4346459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.